Someone reads the 24.2 percent figure, wants it now, and ramps both compounds hard in the first fortnight
Glutathione is produced by the liver to protect the body from free radicals, heavy metals, and toxins
After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )
Compound 4 (1.94 g, 2.47 mmol), H-Lys-OMe2HCl (0.24 g, 1.03 mmol), PYBOP (1.62 g, 3.10 mmol) and HOBT (0.42 g, 3.10 mmol) were dissolved in DMF (40 mL) under nitrogen atmosphere and ice bath conditions